Literature DB >> 20602499

Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer.

M M Aloysius1, A M Zaitoun, S Awad, M Ilyas, B J Rowlands, D N Lobo.   

Abstract

BACKGROUND: This study investigated the association of mucins and cluster of differentiation (CD) 56 with vascular and perineural invasion and survival in patients with periampullary cancer.
METHODS: Immunohistochemical staining was performed on formalin-fixed pancreatic tissue microarrays (cancer, chronic pancreatitis and normal pancreatic tissue) constructed from 126 pancreatic resections (cancer, 104; chronic pancreatitis, 22). Mucin (MUC) 1, MUC4 and MUC5AC expression was quantified using the immunohistochemical score (range 0-300), MUC3 expression was described as membranous or cytoplasmic, and expression of CD56, MUC2 and MUC6 as present or absent.
RESULTS: In cancers, vascular invasion correlated with overexpression (immunohistochemical score of 100 or more) of MUC1 (P = 0.003) and presence of MUC6 (P = 0.024), and perineural invasion correlated with overexpression of MUC5AC (P = 0.015). Reduced survival was observed with overexpression of MUC4 (P = 0.032) and MUC5AC (P = 0.048), membranous expression of MUC3 (P = 0.048), and presence of CD56 (P = 0.041). Perineural invasion also correlated with CD56 expression (P = 0.001). Overexpression of MUC4 and MUC5AC correlated with tumour recurrence (P = 0.001 and P = 0.034 respectively). Multivariable analysis identified membranous expression of MUC3 (P = 0.023), lymphatic invasion (P = 0.015) and perineural invasion (P = 0.004) as independent predictors of poor survival.
CONCLUSION: Mucins and CD56 may be markers of prognosis in patients with periampullary cancer. Copyright (c) 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602499     DOI: 10.1002/bjs.7107

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  19 in total

1.  Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.

Authors:  Mengying Yao; Weihong Zhang; Qingxian Zhang; Lihua Xing; Aiguo Xu; Qiuhong Liu; Bing Cui
Journal:  Lung       Date:  2011-10-01       Impact factor: 2.584

Review 2.  Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis.

Authors:  Xing Huang; Xin Wang; Shi-Ming Lu; Chen Chen; Jie Wang; Yan-Yan Zheng; Bin-Hui Ren; Lin Xu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Transmembrane mucin MUC13 distinguishes intraductal papillary mucinous neoplasms from non-mucinous cysts and is associated with high-risk lesions.

Authors:  Zachary E Stiles; Sheema Khan; Kurt T Patton; Meena Jaggi; Stephen W Behrman; Subhash C Chauhan
Journal:  HPB (Oxford)       Date:  2018-08-14       Impact factor: 3.647

4.  Predictive value of tumor proliferative indices in periampullary cancers: Ki-67, mitotic activity index (MI) and volume corrected mitotic index (M/V) using tissue microarrays.

Authors:  Mark M Aloysius; Shivanthi J De Silva Hewavisenthi; Timothy E Bates; Brian J Rowlands; Dileep N Lobo; Abed M Zaitoun
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

5.  Functional p38 MAPK identified by biomarker profiling of pancreatic cancer restrains growth through JNK inhibition and correlates with improved survival.

Authors:  Yi Zhong; Yoshiki Naito; Leslie Cope; Salvador Naranjo-Suarez; Tyler Saunders; Seung-Mo Hong; Michael G Goggins; Joseph M Herman; Christopher L Wolfgang; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

Review 6.  Clinicopathological features and surgical outcomes of intraductal tubulopapillary neoplasm of the pancreas: a systematic review.

Authors:  Keiichi Date; Takehiro Okabayashi; Yasuo Shima; Jun Iwata; Tatsuaki Sumiyoshi; Akihito Kozuki; Sojiro Morita; Yasuhiro Hata; Yoshihiro Noda; Akihito Nishioka; Manabu Matsumoto
Journal:  Langenbecks Arch Surg       Date:  2016-03-21       Impact factor: 3.445

7.  Mucins differently expressed in various ampullary adenocarcinomas.

Authors:  Tao Wang; Ye M Liang; Peng Hu; Yu F Cheng
Journal:  Diagn Pathol       Date:  2011-10-25       Impact factor: 2.644

8.  Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.

Authors:  Ana C Tahira; Márcia S Kubrusly; Michele F Faria; Bianca Dazzani; Rogério S Fonseca; Vinicius Maracaja-Coutinho; Sergio Verjovski-Almeida; Marcel C C Machado; Eduardo M Reis
Journal:  Mol Cancer       Date:  2011-11-13       Impact factor: 27.401

9.  A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor.

Authors:  Hiroaki Shibahara; Michiyo Higashi; Seiya Yokoyama; Karine Rousseau; Iwao Kitazono; Masahiko Osako; Hiroshi Shirahama; Yukie Tashiro; Yasuhiro Kurumiya; Michihiko Narita; Shingo Kuze; Hiroshi Hasagawa; Takehito Kato; Hitoshi Kubota; Hideaki Suzuki; Toshiyuki Arai; Yu Sakai; Norihiro Yuasa; Masahiko Fujino; Shinji Kondo; Yoshichika Okamoto; Tatsuyoshi Yamamoto; Takashi Hiromatsu; Eiji Sasaki; Kazuhisa Shirai; Satoru Kawai; Koutarou Hattori; Hideki Tsuji; Osamu Okochi; Masaki Sakamoto; Akinobu Kondo; Naomi Konishi; Surinder K Batra; Suguru Yonezawa
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

10.  The Association between Survival and the Pathologic Features of Periampullary Tumors Varies over Time.

Authors:  Jennifer K Plichta; Anjali S Godambe; Zachary Fridirici; Sherri Yong; James M Sinacore; Gerard J Abood; Gerard V Aranha
Journal:  HPB Surg       Date:  2014-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.